TD Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,796
| Closed | -$137K | – | 1228 |
|
|
2024
Q4 | $137K | Hold |
10,796
| – | – | ﹤0.01% | 1235 |
|
|
2024
Q3 | $153K | Hold |
10,796
| – | – | ﹤0.01% | 1373 |
|
|
2024
Q2 | $149K | Hold |
10,796
| – | – | ﹤0.01% | 1348 |
|
|
2024
Q1 | $178K | Sell |
10,796
-44,400
| -80% | -$733K | ﹤0.01% | 1365 |
|
|
2023
Q4 | $806K | Hold |
55,196
| – | – | ﹤0.01% | 1222 |
|
|
2023
Q3 | $677K | Buy |
55,196
+27,598
| +100% | +$339K | ﹤0.01% | 1217 |
|
|
2023
Q2 | $330K | Hold |
27,598
| – | – | ﹤0.01% | 1326 |
|
|
2023
Q1 | $369K | Sell |
27,598
-18,734
| -40% | -$250K | ﹤0.01% | 1312 |
|
|
2022
Q4 | $997K | Hold |
46,332
| – | – | ﹤0.01% | 1144 |
|
|
2022
Q3 | $909K | Sell |
46,332
-1
| -0% | -$20 | ﹤0.01% | 1197 |
|
|
2022
Q2 | $829K | Buy |
46,333
+8,884
| +24% | +$159K | ﹤0.01% | 1212 |
|
|
2022
Q1 | $371K | Hold |
37,449
| – | – | ﹤0.01% | 1372 |
|
|
2021
Q4 | $631K | Buy |
37,449
+20,593
| +122% | +$347K | ﹤0.01% | 1355 |
|
|
2021
Q3 | $400K | Hold |
16,856
| – | – | ﹤0.01% | 1423 |
|
|
2021
Q2 | $400K | Buy |
+16,856
| New | +$400K | ﹤0.01% | 1411 |
|